A starting dose, step schedule, and measurement plan are recorded so progress can be compared visit to visit
On Medicare, both join the GLP-1 bridge on July 1, 2026, which can bring eligible patients down to around $50 a month
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility available
A patient stopping semaglutide and waiting 4 weeks before starting tirzepatide 2.5 mg is essentially starting with a near-clean receptor slate, which may reduce the risk of compounded nausea
By mimicking the effects of the incretin hormone GLP-1, semaglutide enhances insulin secretion and inhibits glucagon release, leading to improved blood sugar control
When to stop or reconsider GLP-1 therapy Not every Hashimoto's patient should stay on GLP-1 medications indefinitely